Study Summary
This trial is testing a new cancer drug to see if it is safe and effective. The drug will be given to people with ovarian, endometrial, lung, or breast cancer. The trial will test different doses of the drug to see what is the best dose to give to people.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
13 Primary · 23 Secondary · Reporting Duration: From date of first dose of study drug until first documentation of CR or PR (up to approximately 2 years)
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
9 Treatment Groups
Dose Confirmation Part: MORAb-202 (0.9 mg/kg) With Corticosteroid Pretreatment
1 of 9
Dose Confirmation Part: Farletuzumab ecteribulin (25 mg/m^2)
1 of 9
Dose Confirmation Part: MORAb-202 (33 mg/m^2)
1 of 9
Dose Confirmation Part: MORAb-202 (25 mg/m^2)
1 of 9
Dose Confirmation Part: MORAb-202 (1.2 mg/kg) With Corticosteroid Pretreatment
1 of 9
Dose Confirmation Part: MORAb-202 (0.9 mg/kg) Without Corticosteroid Pretreatmen...
1 of 9
Dose Escalation: Farletuzumab ecteribulin
1 of 9
Dose Escalation: MORAb-202
1 of 9
Dose Confirmation Part: Farletuzumab ecteribulin (33 mg/m^2)
1 of 9
Experimental Treatment
55 Total Participants · 9 Treatment Groups
Primary Treatment: Farletuzumab ecteribulin · No Placebo Group · Phase 1 & 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are any Canadian treatment centers presently executing this exploration?
"Currently, this medical trial is seeking participants from 9 distinct sites. These locations span Stanford, New York and Camden amongst other cities - so you can choose the location that requires minimal travel if you decide to join." - Anonymous Online Contributor
Is the enrollment period for this research study still open?
"As indicated on clinicaltrials.gov, recruitment for this medical trial remains ongoing; the study being first published on August 6th 2020 and most recently amended on October 31st 2022." - Anonymous Online Contributor
How many volunteers are contributing to this clinical research?
"Eisai Inc., the sponsor of this trial, needs to find 55 qualified participants in order for it to be executed. The trial locations include Stanford University School of Medicine (Stanford, California) and Columbia University Medical Center (New York)." - Anonymous Online Contributor